Koi Herpesvirus Disease: Diagnosis, Testing, and Outbreak Control

Bottom line

Koi herpesvirus disease (KHVD) is a highly consequential, contagious disease of koi and common carp caused by cyprinid herpesvirus 3 (CyHV-3). Suspect it when a compatible-temperature outbreak produces respiratory distress, gill necrosis, lethargy, skin change, and rapid losses, but confirm with a qualified diagnostic laboratory because ammonia, nitrite, parasites, and bacterial gill disease can closely overlap. A negative result from a clinically normal survivor does not by itself exclude previous infection or carrier risk.[1]

Host, outbreak, and regulatory context

Clinical disease is centered on koi and common carp, Cyprinus carpio. Merck describes disease at water temperatures of 22°–27°C (72°–81°F), with maximal mortality at 22°–25.5°C (72°–78°F), and reports that mortality can reach 80%–100%.[1] These are disease-associated ranges and reported outbreak mortality, not universal predictions for every exposed collection. Fish of any age may be affected, with potentially greater losses among younger fish.

Obtain the acquisition and movement history before disturbing the system. Record additions, returns from shows, shared water or equipment, source ponds, recent transport, temperature changes, mortalities by day, and contact between systems. Map every tank or pond connected by water, nets, siphons, footwear, filtration, or animal movement. Stop elective movement and sales immediately when KHVD is a credible differential.

In the US, Merck states that confirmed KHV cases must be reported to the State Veterinarian and the USDA Area Veterinarian in Charge.[1] Confirm current jurisdictional requirements with the diagnostic laboratory and animal-health authorities. Reporting is not synonymous with one automatic disposition in every jurisdiction, but it should not be delayed while informal repeat testing is pursued.

Presentation and differential diagnosis

Respiratory distress and severe gill disease are central clinical clues. Affected fish may be lethargic, remain near the surface, and have gills with a mottled red-and-white appearance, necrosis, or hemorrhage. Skin hemorrhage or discoloration, excess mucus, sunken eyes, abnormal swimming, anorexia, and sudden mortality may occur. None is pathognomonic.[1]

Assess the system and fish in parallel. Measure temperature, dissolved oxygen concentration and saturation, pH, total ammonia nitrogen with unionized ammonia calculation when appropriate, nitrite, alkalinity, salinity, and recent chemical exposures. Examine fresh gill, skin, and fin wet mounts for parasites and evaluate bacterial disease rather than assuming that every necrotic gill is viral. Merck warns that severe bacterial or parasitic disease can mask KHV as the primary driver.[1]

Key differentials include ammonia toxicosis, nitrite-associated methemoglobinemia, hypoxia, high carbon dioxide, gas supersaturation, columnaris and other bacterial branchitis, monogeneans, ichthyophthiriasis, and other viral diseases of carp. Coinfection is possible. Finding parasites or culturing bacteria does not automatically close the KHV branch when the mortality pattern, host, lesions, and temperature remain compatible.

Stabilization and sample strategy

Correct immediately lethal water-quality failures while preserving diagnostic information. Increase safe aeration when hypoxia is possible, restore circulation, discontinue suspect chemicals, and document pretreatment measurements. Use dedicated equipment and handle affected systems last. Avoid moving live suspect fish through shared clinical water circuits.

Coordinate specimens with the receiving laboratory before collection. Merck states that freshly dead fish shipped on ice and received within 24 hours should be adequate and that PCR or virus isolation and identification can confirm infection in dead animals.[1] Select freshly dead or moribund fish that represent the active syndrome; chronically decomposed carcasses weaken histopathology and microbiology. Submit paired fresh/chilled and fixed tissues as directed so molecular testing can be interpreted alongside lesions and competing diagnoses.

Gill, kidney, spleen, intestine, brain, mucus, blood, feces, or nonlethal gill samples may have roles depending on the assay and clinical state. Do not improvise pooling, preservatives, or swab media. Label individual fish and system of origin, retain the temperature and mortality timeline, and request evaluation for major gill differentials. A positive PCR establishes detection of target nucleic acid in that specimen; clinical disease attribution still uses host, signs, pathology, and outbreak context.

PCR interpretation and carrier testing

Test performance depends on specimen, disease phase, viral burden, processing, inhibition control, and assay validation. Loose and colleagues validated a PCR-lateral-flow assay using 54 gill tissue samples and 46 kidney samples with known KHV status, plus 20 gill swabs from deceased common carp during a confirmed outbreak. In a single run, it produced false-negative results among positive specimens, and the investigators identified PCR inhibition in unextracted gill-swab material.[2] This study evaluates one assay and panel; its performance figures should not be transferred automatically to another laboratory method.

Clinically normal fish create a different question from acutely diseased fish. Merck cautions that nonlethal tests can be false-negative in clinically normal fish and that a negative blood result may reflect true absence, early infection before measurable antibody, or waning antibody in a previously infected carrier.[1] Therefore, a single negative result is not a certificate that a survivor is safe to mix or sell.

Soto and colleagues compared ELISA with whole-blood and gill qPCR in experimentally infected koi over an 11-month period. In that experimental population, ELISA was superior to those qPCR specimens for detecting previous exposure, and the authors recommended combining ELISA with gill qPCR when assessing suspected carrier-state fish.[3] That result supports complementary testing for the carrier question; it does not make serology a stand-alone diagnosis of active KHVD or prescribe a universal surveillance schedule.

Ask the laboratory which assay is validated for active disease, previous exposure, or surveillance, and whether serial or complementary sampling is advised. Interpret a negative result against pretest probability. If a compatible outbreak continues, revisit fish selection, tissue choice, collection timing, inhibition, temperature history, and alternate diagnoses rather than simply repeating the same low-yield sample.

Population control and biosecurity

There is no antiviral treatment demonstrated to clear CyHV-3 from an infected population. Supportive care and correction of water-quality problems may reduce secondary losses, but clinical recovery does not equal elimination. Merck strongly recommends depopulation when KHV is confirmed in a koi population because survivors can remain carriers and expose naive fish.[1]

Temperature manipulation requires precise counseling. Merck reports that mortality decreases or stops as water temperature approaches 30°C (86°F), while survivors retain carrier status.[1] Warming is therefore not viral eradication, a cure, or permission to move recovered fish. Rapid temperature manipulation can also stress fish and alter other disease processes; coordinate any change with the diagnostic and population plan.

Until disposition is resolved, maintain strict separation of water, nets, hoses, pumps, transport containers, and personnel workflow. Remove organic debris before applying an authority- or laboratory-directed disinfection protocol, because disinfectant efficacy depends on concentration, contact time, temperature, water chemistry, and surface cleanliness. Prevent discharge or animal movement that could expose other carp populations.

For prevention, Merck recommends a minimum quarantine of 30 days at 24°C (75°F) for koi. It also describes placing a new fish after quarantine in an isolated area with a few fish from the established population and monitoring for at least 2 weeks as an added precaution.[1] This is published guidance, not proof that quarantine eliminates carrier risk. Design quarantine around independent water and equipment, daily observation, records, and a predefined testing and mortality-submission plan.

Prognosis and client communication

Separate the prognosis of an individual fish from the risk posed by the population. Some fish may survive the clinical episode, but survival creates a long-term biosecurity problem because apparently recovered animals may remain infected. Discuss financial value, genetic value, welfare, regulatory obligations, environmental exposure, diagnostic uncertainty, and the consequences for every connected pond.

Provide written instructions that prohibit sale, show attendance, breeding transfers, or equipment sharing while status is unresolved. Explain that antibiotics may be indicated for a documented secondary bacterial infection but do not treat the virus. If depopulation is selected, coordinate humane euthanasia, carcass handling, cleaning, disinfection, fallowing, and restocking with aquatic-animal-health and regulatory guidance.

Frequently Asked Questions

Does a positive CyHV-3 PCR prove that KHV caused the deaths?

It proves that target nucleic acid was detected in the tested specimen. Attribute disease by combining the result with susceptible host, outbreak pattern, temperature, lesions, histopathology, and exclusion or documentation of competing gill disease.

Does one negative PCR clear a clinically normal koi?

No. Merck warns that nonlethal tests can be false-negative in clinically normal fish and that negative blood testing cannot by itself exclude carrier status.[1]

Which fish should be submitted first?

Coordinate with the laboratory and prioritize freshly dead or moribund fish representative of active disease. Merck states that freshly dead specimens shipped on ice and received within 24 hours should be adequate.[1]

Can warming the pond cure KHV?

No. Merck reports that mortality may decrease or stop as water approaches 30°C (86°F), but survivors retain carrier status. Temperature manipulation is not eradication.[1]

Should bacteria or parasites end the KHV workup?

Not automatically. Merck notes that severe bacterial or parasitic disease may mask KHV as the primary cause of gill lesions. Interpret coinfections with the host, temperature, lesions, and mortality pattern.[1]

Is there a validated antiviral treatment?

No antiviral has been shown to clear an infected population. Supportive care and treatment of documented secondary disease do not remove carrier risk, and Merck strongly recommends depopulation for a confirmed koi population.[1]

How should suspected carriers be tested?

Use the diagnostic laboratory's carrier-state protocol rather than a single convenient specimen. In an experimental 11-month koi study, Soto and colleagues found ELISA superior to whole-blood and gill qPCR for previous exposure and recommended combining ELISA with gill qPCR.[3]